Skip to results
Modify your search
NARROW
1-20 of 75
Authors: Sameer Agnihotri
Sort by
Journal Article
ACCEPTED MANUSCRIPT
H3K27M diffuse midline glioma is homologous recombination defective and sensitized to radiotherapy and NK cell-mediated antitumor immunity by PARP inhibition
Get access
Yupei Guo and others
Neuro-Oncology, noaf097, https://doi.org/10.1093/neuonc/noaf097
Published: 10 April 2025
Journal Article
Immuno-epidemiologic mapping of human leukocyte antigen diversity across glioma patient cohorts
Get access
Zujian Xiong and others
Neuro-Oncology, noaf040, https://doi.org/10.1093/neuonc/noaf040
Published: 14 February 2025
Journal Article
TMOD-35. EGFRVIII OVEREXPRESSION AND LOSS OF MOUSE SPECIFIC CDKN2A IN GLIAL CELLS LEADS TO SPONTANEOUS GLIOMAGENESIS IN A NOVEL MOUSE MODEL
Olivia Singh and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii327, https://doi.org/10.1093/neuonc/noae165.1299
Published: 11 November 2024
Journal Article
TMIC-65. USING BIOINFORMATICS TO INVESTIGATE THE TUMOR MICROENVIRONMENT OF DIFFUSE MIDLINE GLIOMA
Havisha Kalpatthi and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii313, https://doi.org/10.1093/neuonc/noae165.1243
Published: 11 November 2024
Journal Article
EXTH-06. DEVELOPMENT OF ANTISENSE OLIGONUCLEOTIDE THERAPY AGAINST ZFTA-RELA EPENDYMOMA
Nicholas Laboe and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii237, https://doi.org/10.1093/neuonc/noae165.0937
Published: 11 November 2024
Journal Article
TMET-39. DUAL TARGETING OF MAP KINASE SIGNALING AND METABOLISM IS A THERAPEUTIC VULNERABILITY IN PEDIATRIC DIFFUSE MIDLINE GLIOMAS
Taylor Gatesman and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii296, https://doi.org/10.1093/neuonc/noae165.1177
Published: 11 November 2024
Journal Article
TMET-22. OVERCOMING RESISTANCE: PANOBINOSTAT SENSITIZES 2DG-RESISTANT PEDIATRIC HIGH-GRADE GLIOMAS WITH H3.3 K27M/G34R MUTATIONS TO APOPTOSIS
Tracy Miller and others
Neuro-Oncology, Volume 26, Issue Supplement_8, November 2024, Page viii292, https://doi.org/10.1093/neuonc/noae165.1160
Published: 11 November 2024
Journal Article
DIPG-85. MALT1 IN H3K27-ALTERED DIFFUSE MIDLINE GLIOMA
Hannah E Butterfield and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.138
Published: 18 June 2024
Journal Article
DIPG-79. METTL16 AS A THERAPEUTIC VULNERABILITY IN H3K27M MUTANT DMG CELLS
Akanksha Chilukuri and others
Neuro-Oncology, Volume 26, Issue Supplement_4, June 2024, Page 0, https://doi.org/10.1093/neuonc/noae064.132
Published: 18 June 2024
Journal Article
TMIC-04. IMMUNE PROFILING OF PEDIATRIC ONCOHISTONE GLIOMAS REVEALS DIVERSE MYELOID POPULATIONS AND TUMOR-PROMOTING BEHAVIORS
Augusto Faria Andrade and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v278, https://doi.org/10.1093/neuonc/noad179.1070
Published: 10 November 2023
Journal Article
MODL-32. EGFRVIII OVEREXPRESSION AND LOSS OF MOUSE SPECIFIC CDKN2A IN GLIAL CELLS LEADS TO GLIOMAGENESIS IN A NOVEL MOUSE MODEL
Olivia Singh and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Pages v305–v306, https://doi.org/10.1093/neuonc/noad179.1183
Published: 10 November 2023
Journal Article
CNSC-34. BAF60C/SMARCD3 MODULATES CEREBELLUM DEVELOPMENT AND MEDULLOBLASTOMA METASTASIS
Han Zou and others
Neuro-Oncology, Volume 25, Issue Supplement_5, November 2023, Page v30, https://doi.org/10.1093/neuonc/noad179.0118
Published: 10 November 2023
Journal Article
DIPG-19. BAF COMPLEX PERTURBATION AS A NOVEL THERAPEUTIC OPPORTUNITY IN H3K27M PEDIATRIC GLIOMA
Eshini Panditharatna and others
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Pages i16–i17, https://doi.org/10.1093/neuonc/noad073.066
Published: 12 June 2023
Journal Article
DIPG-39. SIGNALING NETWORKS IN PEDIATRIC-TYPE DIFFUSE HIGH GRADE GLIOMAS
Sophie A Herbst and others
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i22, https://doi.org/10.1093/neuonc/noad073.086
Published: 12 June 2023
Journal Article
HGG-05. PERTURBING GABAERGIC NEURONAL LINEAGE IN DIFFUSE HEMISPHERIC GLIOMA, H3G34-MUTANT, HIGHLIGHTS CDK6 AS A CLINICALLY ACTIONABLE TARGET
Ilon Liu and others
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i39, https://doi.org/10.1093/neuonc/noad073.154
Published: 12 June 2023
Journal Article
DIPG-08. THE LANDSCAPE OF TUMOR CELL STATES AND SPATIAL ORGANIZATION IN H3-K27M MUTANT DIFFUSE MIDLINE GLIOMA ACROSS AGE AND LOCATION
Ilon Liu and others
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i14, https://doi.org/10.1093/neuonc/noad073.055
Published: 12 June 2023
Journal Article
DIPG-36. H3K27M HISTONE MUTANT GLIOMAS ARE SENSITIVE TO METHIONINE LOSS AND MAT2A INHIBITION THROUGH A NOVEL FEEDBACK MECHANISM BETWEEN AMD1 AND METTL16
Akanksha Chilukuri and others
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Page i21, https://doi.org/10.1093/neuonc/noad073.083
Published: 12 June 2023
Journal Article
DIPG-46. TARGETING THE METABOLIC ERK5-PFKFB3 AXIS IN PEDIATRIC DIFFUSE MIDLINE GLIOMA
Stephanie Casillo and others
Neuro-Oncology, Volume 25, Issue Supplement_1, June 2023, Pages i23–i24, https://doi.org/10.1093/neuonc/noad073.093
Published: 12 June 2023
Journal Article
Sterol regulatory element-binding protein 2 maintains glioblastoma stem cells by keeping the balance between cholesterol biosynthesis and uptake
Danling Gu and others
Neuro-Oncology, Volume 25, Issue 9, September 2023, Pages 1578–1591, https://doi.org/10.1093/neuonc/noad060
Published: 19 March 2023
Journal Article
DDDR-10. INHIBITING INSULIN SIGNALING REVERSES RESISTANCE TO PI3K-MTOR INHIBITORS IN AGGRESSIVE PEDIATRIC HIGH-GRADE GLIOMAS
Taylor Gatesman and others
Neuro-Oncology, Volume 24, Issue Supplement_7, November 2022, Page vii100, https://doi.org/10.1093/neuonc/noac209.375
Published: 14 November 2022
Advertisement
Advertisement